B lymphocytes in abdominal aortic aneurysms

Atherosclerosis

Volumn 242, Issue 1, 2015, Pages 311-317

  Zhang, Lili ^a   Wang, Yi ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Aortic aneurysm; B lymphocyte; Cytokine; Immunoglobulin; Pathogenesis

Indexed keywords

CYTOKINE; AUTACOID; IMMUNOGLOBULIN G; MATRIX METALLOPROTEINASE;

ABDOMINAL AORTA ANEURYSM; B LYMPHOCYTE; CYTOKINE PRODUCTION; DISEASE COURSE; HUMAN; IMMUNOGLOBULIN PRODUCTION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SECONDARY PREVENTION; ABDOMINAL AORTA; ANIMAL; IMMUNOLOGY; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; B-LYMPHOCYTES; CYTOKINES; DISEASE PROGRESSION; HUMANS; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; MATRIX METALLOPROTEINASES; SIGNAL TRANSDUCTION;

EID: 84938075622     PISSN: 00219150     EISSN: 18791484     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2015.07.036     Document Type: Review

References (74)

1. Gillum R.F. Epidemiology of aortic aneurysm in the United States. J.Clin. Epidemiol. 1995, 48(11):1289-1298. [Epub 1995/11/01. PubMed PMID: 7490591].
2. Heron M. Deaths: leading causes for 2004. National vital statistics reports: from the Centers for Disease Control and Prevention, National Center for Health Statistics. Natl. Vital Stat. Syst. 2007, 56(5):1-95. [Epub 2007/12/21. PubMed PMID: 18092547].
3. Sakalihasan N., Limet R., Defawe O.D. Abdominal aortic aneurysm. Lancet 2005, 365(9470):1577-1589. [Epub 2005/05/04. PubMed PMID: 15866312]. 10.1016/s0140-6736(05)66459-8.
4. Harthun N.L. Current issues in the treatment of women with abdominal aortic aneurysm. Gend. Med. 2008, 5(1):36-43. [Epub 2008/04/19. PubMed PMID: 18420164].
5. Upchurch G.R., Schaub T.A. Abdominal aortic aneurysm. Am. Family Physician 2006, 73(7):1198-1204. [Epub 2006/04/21. PubMed PMID: 16623206].
6. Lederle F.A., Johnson G.R., Wilson S.E., Gordon I.L., Chute E.P., Littooy F.N., et al. Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators. J.Vasc. Surg. 1997, 26(4):595-601. [Epub 1997/11/14. PubMed PMID: 9357459].
7. Lindholt J.S., Heegaard N.H., Vammen S., Fasting H., Henneberg E.W., Heickendorff L. Smoking, but not lipids, lipoprotein(a) and antibodies against oxidised LDL, is correlated to the expansion of abdominal aortic aneurysms. Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2001, 21(1):51-56. [Epub 2001/02/15PubMed PMID: 11170878]. 10.1053/ejvs.2000.1262.
8. Vardulaki K.A., Walker N.M., Day N.E., Duffy S.W., Ashton H.A., Scott R.A. Quantifying the risks of hypertension, age, sex and smoking in patients with abdominal aortic aneurysm. Br. J. Surg. 2000, 87(2):195-200. [Epub 2000/02/15. PubMed PMID: 10671927]. 10.1046/j.1365-2168.2000.01353.x.
9. Brady A.R., Thompson S.G., Fowkes F.G., Greenhalgh R.M., Powell J.T. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004, 110(1):16-21. [Epub 2004/06/24. PubMed PMID: 15210603]. 10.1161/01.cir.0000133279.07468.9f.
10. Reed D., Reed C., Stemmermann G., Hayashi T. Are aortic aneurysms caused by atherosclerosis?. Circulation 1992, 85(1):205-211. [Epub 1992/01/01. PubMed PMID: 1728451].
11. Golledge J., Muller J., Daugherty A., Norman P. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vasc. Biol. 2006, 26(12):2605-2613. [Epub 2006/09/16. PubMed PMID: 16973970]. 10.1161/01.ATV.0000245819.32762.cb.
12. Wassef M., Baxter B.T., Chisholm R.L., Dalman R.L., Fillinger M.F., Heinecke J., et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J.Vasc. Surg. 2001, 34(4):730-738. [Epub 2001/10/23. PubMed PMID: 11668331]. 10.1067/mva.2001.116966.
13. Shimizu K., Mitchell R.N., Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2006, 26(5):987-994. [Epub 2006/02/25. PubMed PMID: 16497993]. 10.1161/01.ATV.0000214999.12921.4f.
14. Zhang J., Bockler D., Ryschich E., Klemm K., Schumacher H., Schmidt J., et al. Impaired fas-induced apoptosis of T lymphocytes in patients with abdominal aortic aneurysms. J.Vasc. Surg. 2007, 45(5):1039-1046. [Epub 2007/03/14. PubMed PMID: 17350784]. 10.1016/j.jvs.2006.12.055.
15. Caligiuri G., Rossignol P., Julia P., Groyer E., Mouradian D., Urbain D., et al. Reduced immunoregulatory CD31+ T cells in patients with atherosclerotic abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 2006, 26(3):618-623. [Epub 2005/12/17. PubMed PMID: 16357310]. 10.1161/01.ATV.0000200380.73876.d9.
16. Ocana E., Bohorquez J.C., Perez-Requena J., Brieva J.A., Rodriguez C. Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms. Atherosclerosis 2003, 170(1):39-48. [Epub 2003/09/06. PubMed PMID: 12957681].
17. Galle C., Schandene L., Stordeur P., Peignois Y., Ferreira J., Wautrecht J.C., et al. Predominance of type 1 CD4+ T cells in human abdominal aortic aneurysm. Clin. Exp. Immunol. 2005, 142(3):519-527. [Epub 2005/11/22. PubMed PMID: 16297165; PubMed Central PMCID: PMCPmc1809544]. 10.1111/j.1365-2249.2005.02938.x.
18. Pagano M.B., Zhou H.F., Ennis T.L., Wu X., Lambris J.D., Atkinson J.P., et al. Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation 2009, 119(13):1805-1813. [Epub 2009/03/25. PubMed PMID: 19307471; PubMed Central PMCID: PMCPmc2758616]. 10.1161/circulationaha.108.832972.
19. Zhou H.F., Yan H., Stover C.M., Fernandez T.M., Rodriguez de Cordoba S., Song W.C., et al. Antibody directs properdin-dependent activation of the complement alternative pathway in a mouse model of abdominal aortic aneurysm. Proc. Natl. Acad. Sci. U. S. A. 2012, 109(7):E415-E422. [Epub 2012/02/07. PubMed PMID: 22308431; PubMed Central PMCID: PMCPmc3289386]. 10.1073/pnas.1119000109.
20. Ray A., Basu S., Williams C.B., Salzman N.H., Dittel B.N. Anovel IL-10-independent regulatory role for B cells in suppressing autoimmunity by maintenance of regulatory T cells via GITR ligand. J.Immunol. (Baltim. Md 1950) 2012, 188(7):3188-3198. [Epub 2012/03/01. PubMed PMID: 22368274; PubMed Central PMCID: PMCPmc3311743]. 10.4049/jimmunol.1103354.
21. Xu J.M., Shi G.P. Emerging role of mast cells and macrophages in cardiovascular and metabolic diseases. Endocr. Rev. 2012, 33(1):71-108. [Epub 2012/01/14. PubMed PMID: 22240242; PubMed Central PMCID: PMCPmc3365842]. 10.1210/er.2011-0013.
22. Koch A.E., Haines G.K., Rizzo R.J., Radosevich J.A., Pope R.M., Robinson P.G., et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am. J. Pathol. 1990, 137(5):1199-1213. [Epub 1990/11/01. PubMed PMID: 1700620; PubMed Central PMCID: PMCPmc1877681].
23. Freestone T., Turner R.J., Coady A., Higman D.J., Greenhalgh R.M., Powell J.T. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. Arterioscler. Thromb. Vasc. Biol. 1995, 15(8):1145-1151. [Epub 1995/08/01. PubMed PMID: 7627708].
24. Bobryshev Y.V., Lord R.S., Parsson H. Immunophenotypic analysis of the aortic aneurysm wall suggests that vascular dendritic cells are involved in immune responses. Cardiovasc. Surg. Lond. Engl. 1998, 6(3):240-249. [Epub 1998/08/15. PubMed PMID: 9705095].
25. Meher A.K., Johnston W.F., Lu G., Pope N.H., Bhamidipati C.M., Harmon D.B., et al. B2 cells suppress experimental abdominal aortic aneurysms. Am. J. Pathol. 2014, [Epub 2014/09/10. PubMed PMID: 25194661; PubMed Central PMCID: PMCPmc4215033]. 10.1016/j.ajpath.2014.07.006.
26. Bobryshev Y.V., Lord R.S. Vascular-associated lymphoid tissue (VALT) involvement in aortic aneurysm. Atherosclerosis 2001, 154(1):15-21. [Epub 2001/01/04. PubMed PMID: 11137078].
27. Walton L.J., Powell J.T., Parums D.V. Unrestricted usage of immunoglobulin heavy chain genes in B cells infiltrating the wall of atherosclerotic abdominal aortic aneurysms. Atherosclerosis 1997, 135(1):65-71. [Epub 1997/12/12. PubMed PMID: 9395274].
28. Houtkamp M.A., de Boer O.J., van der Loos C.M., van der Wal A.C., Becker A.E. Adventitial infiltrates associated with advanced atherosclerotic plaques: structural organization suggests generation of local humoral immune responses. J.Pathol. 2001, 193(2):263-269. [Epub 2001/02/17PubMed PMID: 11180175]. 10.1002/1096-9896(2000)9999:9999<::aid-path774>3.0.co;2-n.
29. Ocana E., Perez-Requena J., Bohorquez J.C., Brieva J.A., Rodriguez C. Chemokine receptor expression on infiltrating lymphocytes from abdominal aortic aneurysms: role of CXCR4-CXCL12 in lymphoid recruitment. Atherosclerosis 2008, 200(2):264-270. [Epub 2008/02/19PubMed PMID: 18281050]. 10.1016/j.atherosclerosis.2007.12.043.
30. Chew D.K., Knoetgen J., Xia S., Tilson M.D. The role of a putative microfibrillar protein (80 kDa) in abdominal aortic aneurysm disease. J.Surg. Res. 2003, 114(1):25-29. [Epub 2003/09/19. PubMed PMID: 13678694].
31. Xia S., Ozsvath K., Hirose H., Tilson M.D. Partial amino acid sequence of a novel 40-kDa human aortic protein, with vitronectin-like, fibrinogen-like, and calcium binding domains: aortic aneurysm-associated protein-40 (AAAP-40) [human MAGP-3, proposed]. Biochem. Biophys. Res. Commun. 1996, 219(1):36-39. [Epub 1996/02/06. PubMed PMID: 8619823]. 10.1006/bbrc.1996.0177.
32. Zhou H.F., Yan H., Bertram P., Hu Y., Springer L.E., Thompson R.W., et al. Fibrinogen-specific antibody induces abdominal aortic aneurysm in mice through complement lectin pathway activation. Proc. Natl. Acad. Sci. U. S. A. 2013, 110(46):E4335-E4344. [Epub 2013/10/30. PubMed PMID: 24167262; PubMed Central PMCID: PMCPmc3831981]. 10.1073/pnas.1315512110.
33. Ando T., Iizuka N., Sato T., Chikada M., Kurokawa M.S., Arito M., et al. Autoantigenicity of carbonic anhydrase 1 in patients with abdominal aortic aneurysm, revealed by proteomic surveillance. Hum. Immunol. 2013, 74(7):852-857. [Epub 2013/04/06PubMed PMID: 23557951]. 10.1016/j.humimm.2013.02.009.
34. Ozsvath K.J., Hirose H., Xia S., Tilson M.D. Molecular mimicry in human aortic aneurysmal diseases. Ann. N. Y. Acad. Sci. 1996, 800:288-293. [Epub 1996/11/18. PubMed PMID: 8959017].
35. Lindholt J.S., Stovring J., Ostergaard L., Urbonavicius S., Henneberg E.W., Honore B., et al. Serum antibodies against chlamydia pneumoniae outer membrane protein cross-react with the heavy chain of immunoglobulin in the wall of abdominal aortic aneurysms. Circulation 2004, 109(17):2097-2102. [Epub 2004/05/01. PubMed PMID: 15117850]. 10.1161/01.cir.0000127772.58427.7e.
36. Forester N.D., Cruickshank S.M., Scott D.J., Carding S.R. Functional characterization of T cells in abdominal aortic aneurysms. Immunology 2005, 115(2):262-270. [Epub 2005/05/12. PubMed PMID: 15885133; PubMed Central PMCID: PMCPmc1782141]. 10.1111/j.1365-2567.2005.02157.x.
37. Vucevic D., Maravic-Stojkovic V., Vasilijic S., Borovic-Labudovic M., Majstorovic I., Radak D., et al. Inverse production of IL-6 and IL-10 by abdominal aortic aneurysm explant tissues in culture. Cardiovasc. Pathol. Off. J. Soc. Cardiovasc. Pathol. 2012, 21(6):482-489. [Epub 2012/03/27PubMed PMID: 22445549]. 10.1016/j.carpath.2012.02.006.
38. Middleton R.K., Bown M.J., Lloyd G.M., Jones J.L., London N.J., Sayers R.D. Characterisation of Interleukin-8 and monocyte chemoattractant protein-1 expression within the abdominal aortic aneurysm and their association with mural inflammation. Eur. J. Vasc. Endovasc. Surg. Off. J. Eur. Soc. Vasc. Surg. 2009, 37(1):46-55. [Epub 2008/11/15. PubMed PMID: 19008128]. 10.1016/j.ejvs.2008.09.013.
39. Lindeman J.H., Abdul-Hussien H., Schaapherder A.F., Van Bockel J.H., Von der Thusen J.H., Roelen D.L., et al. Enhanced expression and activation of pro-inflammatory transcription factors distinguish aneurysmal from atherosclerotic aorta: IL-6- and IL-8-dominated inflammatory responses prevail in the human aneurysm. Clin. Sci. (Lond. Engl. 1979) 2008, 114(11):687-697. [Epub 2007/12/15. PubMed PMID: 18078385]. 10.1042/cs20070352.
40. Newman K.M., Jean-Claude J., Li H., Ramey W.G., Tilson M.D. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994, 90(5 Pt 2):Ii224-7. [Epub 1994/11/01. PubMed PMID: 7955258].
41. Frank M.M., Miletic V.D., Jiang H. Immunoglobulin in the control of complement action. Immunol. Res. 2000, 22(2-3):137-146. [Epub 2001/05/08. PubMed PMID: 11339351]. 10.1385/ir:22:2-3:137.
42. Carroll M.C., Isenman D.E. Regulation of humoral immunity by complement. Immunity 2012, 37(2):199-207. [Epub 2012/08/28. PubMed PMID: 22921118]. 10.1016/j.immuni.2012.08.002.
43. Capella J.F., Paik D.C., Yin N.X., Gervasoni J.E., Tilson M.D. Complement activation and subclassification of tissue immunoglobulin G in the abdominal aortic aneurysm. J.Surg. Res. 1996, 65(1):31-33. [Epub 1996/09/01. PubMed PMID: 8895603]. 10.1006/jsre.1996.0339.
44. Ando T., Nagai K., Chikada M., Okamoto K., Kurokawa M., Kobayashi T., et al. Proteomic analyses of aortic wall in patients with abdominal aortic aneurysm. J.Cardiovasc. Surg. 2011, 52(4):545-555. [Epub 2011/07/28. PubMed PMID: 21792162].
45. Hinterseher I., Erdman R., Donoso L.A., Vrabec T.R., Schworer C.M., Lillvis J.H., et al. Role of complement cascade in abdominal aortic aneurysms. Arterioscler. Thromb. Vasc. Biol. 2011, 31(7):1653-1660. [Epub 2011/04/16 PubMed PMID: 21493888; PubMed Central PMCID: PMCPmc3712630]. 10.1161/atvbaha.111.227652.
46. Ricklin D., Hajishengallis G., Yang K., Lambris J.D. Complement: a key system for immune surveillance and homeostasis. Nat. Immunol. 2010, 11(9):785-797. [Epub 2010/08/20.PubMed PMID: 20720586; PubMed Central PMCID: PMCPmc2924908]. 10.1038/ni. 1923.
47. Wu G., Chen T., Shahsafaei A., Hu W., Bronson R.T., Shi G.P., et al. Complement regulator CD59 protects against angiotensin II-induced abdominal aortic aneurysms in mice. Circulation 2010, 121(11):1338-1346. [Epub 2010/03/10 PubMed PMID: 20212283; PubMed Central PMCID: PMCPmc3057574]. 10.1161/circulationaha.108.844589.
48. Tanaka K., Iwamoto Y., Ito Y., Ishibashi T., Nakabeppu Y., Sekiguchi M., et al. Cyclic AMP-regulated synthesis of the tissue inhibitors of metalloproteinases suppresses the invasive potential of the human fibrosarcoma cell line HT1080. Cancer Res. 1995, 55(13):2927-2935. [Epub 1995/07/01. PubMed PMID: 7796421].
49. Eliason J.L., Hannawa K.K., Ailawadi G., Sinha I., Ford J.W., Deogracias M.P., et al. Neutrophil depletion inhibits experimental abdominal aortic aneurysm formation. Circulation 2005, 112(2):232-240. [Epub 2005/07/13. PubMed PMID: 16009808]. 10.1161/circulationaha.104.517391.
50. Kasashima S., Zen Y., Kawashima A., Konishi K., Sasaki H., Endo M., et al. Inflammatory abdominal aortic aneurysm: close relationship to IgG4-related periaortitis. Am. J. Surg. Pathol. 2008, 32(2):197-204. [Epub 2008/01/29. PubMed PMID: 18223321]. 10.1097/PAS.0b013e3181342f0d.
51. Sakata N., Tashiro T., Uesugi N., Kawara T., Furuya K., Hirata Y., et al. IgG4-positive plasma cells in inflammatory abdominal aortic aneurysm: the possibility of an aortic manifestation of IgG4-related sclerosing disease. Am. J. Surg. Pathol. 2008, 32(4):553-559. [Epub 2008/02/28. PubMed PMID: 18300798]. 10.1097/PAS.0b013e31815a04db.
52. Matsumoto Y., Kasashima S., Kawashima A., Sasaki H., Endo M., Kawakami K., et al. Acase of multiple immunoglobulin G4-related periarteritis: a tumorous lesion of the coronary artery and abdominal aortic aneurysm. Hum. Pathol. 2008, 39(6):975-980. [Epub 2008/04/24. PubMed PMID: 18430457]. 10.1016/j.humpath.2007.10.023.
53. Ito H., Kaizaki Y., Noda Y., Fujii S., Yamamoto S. IgG4-related inflammatory abdominal aortic aneurysm associated with autoimmune pancreatitis. Pathol. Int. 2008, 58(7):421-426. [Epub 2008/06/26. PubMed PMID: 18577110]. 10.1111/j.1440-1827.2008.02247.x.
54. Kasashima S., Zen Y., Kawashima A., Endo M., Matsumoto Y., Kasashima F. Anew clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J.Vasc. Surg. 2009, 49(5):1264-1271. discussion 71. [Epub 2009/02/17. PubMed PMID: 19217746]. 10.1016/j.jvs.2008.11.072.
55. Kasashima S., Zen Y. IgG4-related inflammatory abdominal aortic aneurysm. Curr. Opin. Rheumatol. 2011, 23(1):18-23. [Epub 2010/12/03. PubMed PMID: 21124083]. 10.1097/BOR.0b013e32833ee95f.
56. Hamano H., Kawa S., Horiuchi A., Unno H., Furuya N., Akamatsu T., et al. High serum IgG4 concentrations in patients with sclerosing pancreatitis. N.Engl. J. Med. 2001, 344(10):732-738. [Epub 2001/03/10. PubMed PMID: 11236777]. 10.1056/nejm200103083441005.
57. Mahajan V.S., Mattoo H., Deshpande V., Pillai S.S., Stone J.H. IgG4-related disease. Annu. Rev. Pathol. 2014, 9:315-347. [Epub 2013/10/12. PubMed PMID: 24111912]. 10.1146/annurev-pathol-012513-104708.
58. Stone J.H., Zen Y., Deshpande V. IgG4-related disease. N.Engl. J. Med. 2012, 366(6):539-551. [Epub 2012/02/10. PubMed PMID: 22316447]. 10.1056/NEJMra1104650.
59. Kovanen P.T., Manttari M., Palosuo T., Manninen V., Aho K. Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. Arch. Intern. Med. 1998, 158(13):1434-1439. [Epub 1998/07/17. PubMed PMID: 9665352].
60. Wang J., Cheng X., Xiang M.X., Alanne-Kinnunen M., Wang J.A., Chen H., et al. IgE stimulates human and mouse arterial cell apoptosis and cytokine expression and promotes atherogenesis in Apoe-/- mice. J.Clin. Invest. 2011, 121(9):3564-3577. [Epub 2011/08/09. PubMed PMID: 21821913; PubMed Central PMCID: PMCPmc3163955]. 10.1172/jci46028.
61. Wang J., Lindholt J.S., Sukhova G.K., Shi M.A., Xia M., Chen H., et al. IgE actions on CD4+ T cells, mast cells, and macrophages participate in the pathogenesis of experimental abdominal aortic aneurysms. EMBO Mol. Med. 2014, 6(7):952-969. [Epub 2014/06/26. PubMed PMID: 24963147; PubMed Central PMCID: PMCPmc4119357]. 10.15252/emmm.201303811.
62. Zhang J., Sun J., Lindholt J.S., Sukhova G.K., Sinnamon M., Stevens R.L., et al. Mast cell tryptase deficiency attenuates mouse abdominal aortic aneurysm formation. Circ. Res. 2011, 108(11):1316-1327. [Epub 2011/04/16. PubMed PMID: 21493897; PubMed Central PMCID: PMCPmc3108141]. 10.1161/circresaha.111.243758.
63. Muscari A., Bozzoli C., Gerratana C., Zaca F., Rovinetti C., Zauli D., et al. Association of serum IgA and C4 with severe atherosclerosis. Atherosclerosis 1988, 74(1-2):179-186. [Epub 1988/11/01. PubMed PMID: 3214477].
64. Muscari A., Bozzoli C., Puddu G.M., Rovinetti C., Vallar G., Renzi C., et al. Increased serum IgA levels in subjects with previous myocardial infarction or other major ischemic events. Cardiology 1993, 83(5-6):383-389. [Epub 1993/01/01. PubMed PMID: 8111771].
65. Szekanecz Z., Shah M.R., Pearce W.H., Koch A.E. Human atherosclerotic abdominal aortic aneurysms produce interleukin (IL)-6 and interferon-gamma but not IL-2 and IL-4: the possible role for IL-6 and interferon-gamma in vascular inflammation. Agents Actions 1994, 42(3-4):159-162. [Epub 1994/10/01. PubMed PMID: 7879703].
66. Treska V., Kocova J., Boudova L., Neprasova P., Topolcan O., Pecen L., et al. Inflammation in the wall of abdominal aortic aneurysm and its role in the symptomatology of aneurysm. Cytokines Cell. Mol. Ther. 2002, 7(3):91-97. [Epub 2003/07/10. PubMed PMID: 12850808]. 10.1080/13684730310001652.
67. Abdul-Hussien H., Soekhoe R.G., Weber E., von der Thusen J.H., Kleemann R., Mulder A., et al. Collagen degradation in the abdominal aneurysm: a conspiracy of matrix metalloproteinase and cysteine collagenases. Am. J. Pathol. 2007, 170(3):809-817. [Epub 2007/02/27. PubMed PMID: 17322367; PubMed Central PMCID: PMCPmc1864891]. 10.2353/ajpath.2007.060522.
68. Gabay C. Interleukin-6 and chronic inflammation. Arthritis Res. Ther. 2006, 8(Suppl.2):S3. [Epub 2006/08/11. PubMed PMID: 16899107; PubMed Central PMCID: PMCPmc32]. 10.1186/ar1917.
69. Tedgui A., Mallat Z. Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol. Rev. 2006, 86(2):515-581. [Epub 2006/04/08. PubMed PMID: 16601268]. 10.1152/physrev.00024.2005.
70. Ait-Oufella H., Wang Y., Herbin O., Bourcier S., Potteaux S., Joffre J., et al. Natural regulatory T cells limit angiotensin II-induced aneurysm formation and rupture in mice. Arterioscler. Thromb. Vasc. Biol. 2013, 33(10):2374-2379. [Epub 2013/08/03. PubMed PMID: 23908246]. 10.1161/atvbaha.113.301280.
71. Mallat Z., Heymes C., Ohan J., Faggin E., Leseche G., Tedgui A. Expression of interleukin-10 in advanced human atherosclerotic plaques: relation to inducible nitric oxide synthase expression and cell death. Arterioscler. Thromb. Vasc. Biol. 1999, 19(3):611-616. [Epub 1999/03/12. PubMed PMID: 10073964].
72. Bogdan C., Vodovotz Y., Nathan C. Macrophage deactivation by interleukin 10. J.Exp. Med. 1991, 174(6):1549-1555. [Epub 1991/12/01. PubMed PMID: 1744584; PubMed Central PMCID: PMCPmc2119047].
73. Xiong W., MacTaggart J., Knispel R., Worth J., Persidsky Y., Baxter B.T. Blocking TNF-alpha attenuates aneurysm formation in a murine model. J.Immunol. (Baltim. Md 1950) 2009, 183(4):2741-2746. [Epub 2009/07/22. PubMed PMID: 19620291; PubMed Central PMCID: PMCPmc4028114]. 10.4049/jimmunol.0803164.
74. Reeps C., Pelisek J., Seidl S., Schuster T., Zimmermann A., Kuehnl A., et al. Inflammatory infiltrates and neovessels are relevant sources of MMPs in abdominal aortic aneurysm wall. Pathobiol. J. Immunopathol. Mol. Cell. Biol. 2009, 76(5):243-252. [Epub 2009/10/10. PubMed PMID: 19816084]. 10.1159/000228900.